MAGELLAN LONGEVITY
HomeResearchStudy library › Magnesium Supplementation and Blood Pressure
Study summary · Cardiovascular & vascular aging

What is the effect of magnesium supplementation on blood pressure in both hypertensive and normotensive populations?

In one paragraph

Magnesium Glycinate, a systematic review and meta-analysis in 2709 participants (Hypertension 2025, PMID 41000008) — however, the high heterogeneity across studies suggests that these effects should be interpreted with caution. Magnesium supplementation has a beneficial effect on reducing blood pressure, particularly in populations with hypertension and hypomagnesemia.

Source: Hypertension 2025, PMID 41000008 ↗ · Research map · How Magellan grades evidence · evidence confidence: low

Hypertension · 2025 · PMID 41000008 · DOI 10.1161/HYPERTENSIONAHA.125.25129

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Magnesium supplementation can help lower blood pressure, especially in people with high blood pressure or low magnesium levels, but more research is needed due to study variability.

The question

What is the effect of magnesium supplementation on blood pressure in both hypertensive and normotensive populations?

What they tested

The study aimed to explore the relationship between magnesium supplementation and blood pressure.

How they did it

A systematic review and meta-analysis of 38 randomized controlled trials, involving 2709 participants, was conducted. Studies had a duration of at least 4 weeks, with elemental magnesium doses ranging from 82.3 mg to 637 mg (median 365 mg) and a median intervention period of 12 weeks. Mean differences of changes in blood pressure were calculated using a random effects meta-analysis, and a cubic spline regression model was used for dose-response analysis.

What they found

Magnesium supplementation reduced systolic blood pressure by -2.81 mm Hg and diastolic blood pressure by -2.05 mm Hg overall. Greater reductions in systolic blood pressure were observed in hypertensive individuals on BP-lowering medication (-7.68 mm Hg) and individuals with hypomagnesemia (-5.97 mm Hg). Diastolic blood pressure also saw greater reductions in these groups (-2.96 mm Hg and -4.75 mm Hg, respectively). No statistically significant effect was found in normotensive groups, and no dose-response relationship was identified.

Blood Pressure Reduction with Magnesium Supplementation
Values shown: BP Reduction (mm Hg)
Overall Systolic BP Reduction-2.81
Overall Diastolic BP Reduction-2.05
Hypertensive Systolic BP Reduction-7.68
Hypertensive Diastolic BP Reduction-2.96
Hypomagnesemia Systolic BP Reduction-5.97
Hypomagnesemia Diastolic BP Reduction-4.75

Mean reductions in systolic and diastolic blood pressure (mm Hg) across different populations with magnesium supplementation.

What it means

Magnesium supplementation has a beneficial effect on reducing blood pressure, particularly in populations with hypertension and hypomagnesemia. However, the high heterogeneity across studies suggests that these effects should be interpreted with caution.

Limitations

The study identified high heterogeneity across the included trials. Further larger, well-designed studies are needed to assess higher magnesium doses and refine the dose-response relationship, as well as to identify optimal supplementation strategies for specific subpopulations.

“Magnesium intake resulted in a reduction in systolic blood pressure”— from the published abstract, Hypertension 2025

The paper at a glance

TitleMagnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
JournalHypertension
Year2025
PMID41000008 ↗
DOI10.1161/HYPERTENSIONAHA.125.25129 ↗
TopicCardiovascular & vascular aging

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Magnesium Glycinate

Pooled analyses of randomized trials indicate oral magnesium lowers blood pressure by a small amount—about 2 mmHg in a 34-trial analysis—with larger reductions in people who are hypertensive, magnesium-deficient, or insulin-resistant, and generally no significant effect in normotensive individuals.

Magnesium Glycinate

Magnesium is an essential dietary mineral and the second most abundant intracellular cation, serving as…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What is the effect of magnesium supplementation on blood pressure in both hypertensive and normotensive populations? [Plain-English summary of Hypertension 2025, PMID 41000008, DOI 10.1161/HYPERTENSIONAHA.125.25129]. Magellan Longevity. https://magellanlongevity.com/study/d41000008.html
BibTeX
@misc{magellan_d41000008, title = {What is the effect of magnesium supplementation on blood pressure in both hypertensive and normotensive populations?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/d41000008.html}}, note = {Plain-English summary of PubMed PMID 41000008; DOI 10.1161/HYPERTENSIONAHA.125.25129; Hypertension 2025. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/d41000008.html

Related studies in the Magellan library

All 67 Magellan summaries on cardiovascular & vascular aging →

How this summary was made. Every section above restates what the published abstract of PMID 41000008 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.